VolitionRx Limited Hosting Earnings Conference Call
VolitionRx Limited (NYSE AMERICAN: VNRX) is all set to engage with investors and stakeholders in an upcoming conference call. This event promises to provide crucial insights into the company's financial health and recent business developments.
Details of the Conference Call
On the horizon, the conference call is scheduled for a Friday morning at 8:30 a.m. U.S. Eastern Time. It aims to cover financial and operational results for the current quarter alongside an insightful business update. Participants will find ways to join through various methods outlined below.
Conference Call Event: VolitionRx Limited Second Quarter Earnings and Business Update Conference Call
Date: Friday, August 15, 2025
Time: 8:30 a.m. U.S. Eastern Time / 2:30 p.m. Central European Time
How to Join the Call
Individuals located in the U.S. and Canada can participate by dialing a toll-free number, while those in the U.K. and other international locations have separate dialing options to ensure inclusion. The provided conference ID will assist attendees in connecting swiftly.
U.S. & Canada Dial-in: 1-877-407-9716 (toll-free)
U.K. Dial-in: 0 800 756 3429 (toll-free)
Toll/International: 1-201-493-6779
Conference ID: 13755349
Who Will Be Speaking?
Expect to hear from prominent figures including Louise Batchelor, Group Chief Marketing & Communications Officer, joined by Cameron Reynolds, President, and Group CEO. Other executives, including the Group CFO and Chief Medical Officer, will share their insights during the call, highlighting significant developments from the quarter and future goals.
Accessing the Live Webcast and Replay
For those unable to attend the live call, a webcast link will provide audio access to the session. Moreover, a replay will be accessible for a limited period after the event, allowing even more stakeholders to benefit from the information shared and insights offered.
Replay Dial-in Numbers:
U.S. and Canada: 1-844-512-2921 (toll-free)
International: 1-412-317-6671 (toll)
Please use replay pin number 13755349.
About VolitionRx Limited
VolitionRx is recognized globally for its dedication to advancing the field of epigenetics, focusing on innovative diagnostics to enhance healthcare outcomes for both humans and animals. Their work centers around developing intuitive and cost-effective blood tests aimed at detecting various diseases, including certain cancers, thereby enabling timely medical intervention and monitoring.
The company’s research and development efforts primarily occur in Belgium, supplemented by innovation labs and offices in other locations to foster collaborative progress and breakthroughs in diagnostics.
VolitionRx is committed to ensuring earlier detection and monitoring of diseases, ultimately improving patient quality of life.
Media Inquiries
For any media inquiries, contact Louise Batchelor via email or phone for comprehensive assistance and information.
Investor Relations
Engage with Jeremy Feffer at LifeSci Advisors for investor inquiries regarding the company's performance or future directions.
Frequently Asked Questions
When is the earnings call scheduled?
The earnings call is set for Friday, August 15, 2025, at 8:30 a.m. U.S. Eastern Time.
Who are the key speakers at the conference call?
The call will feature executives including Louise Batchelor, Cameron Reynolds, and other key leaders from VolitionRx.
How can participants join the conference call?
Participants can join by dialing the provided numbers or accessing the live audio webcast via the instructions shared in the release.
What topics will be discussed during the call?
The conference will cover financial results, significant company developments, and upcoming milestones.
Where is VolitionRx focused geographically?
VolitionRx conducts research primarily in Belgium, with additional operations in the U.S. and other locations to drive innovation.
